By Elric Langton | 3 December 2022
If you missed the Poolbeg Pharma (AIM: POLB, OTCQB: POLBF) Capital Markets Day presentation to institutions and investors due to work or other commitments, it is well worth watching it in full. There is a lot of detailed information, as well as Q&A sessions. Plus, the business model and development.
I have also enclosed β¦